Cargando…

Adherence to Subcutaneous Anti-TNF Treatment in Chronic Inflammatory Rheumatism and Therapeutic Patient Education

OBJECTIVE: Poor patient adherence to anti-TNF treatment has proven to be a major roadblock to effective management. Therapeutic patient education (TPE) is now recognized as a crucial tool in managing conditions like chronic inflammatory rheumatism and in improving treatment adherence. This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fayet, Françoise, Fan, Angélique, Rodere, Malory, Savel, Carine, Pereira, Bruno, Soubrier, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047966/ https://www.ncbi.nlm.nih.gov/pubmed/32158200 http://dx.doi.org/10.2147/PPA.S240179

Ejemplares similares

Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis
por: Rodère, Malory, et al.
Publicado: (2022)

Management of inflammatory rheumatic conditions in the elderly
por: Lahaye, Clément, et al.
Publicado: (2019)

The Subcutaneous Nodule of Rheumatism
por: Gollerkeri, P. G.
Publicado: (1938)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
por: Svedbom, Axel, et al.
Publicado: (2017)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
por: Acar, Mustafa, et al.
Publicado: (2018)

Vascular endothelial growth factor levels and rheumatic diseases of the elderly
por: Smets, Perrine, et al.
Publicado: (2016)

Prevalence of Migraine and Neuropathic Pain in Rheumatic Diseases
por: Mathieu, Sylvain, et al.
Publicado: (2020)

Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes
por: Garrouste, Cyril, et al.
Publicado: (2016)

Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trial
por: Beauvais, Catherine, et al.
Publicado: (2022)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
por: Vial, Gaelle, et al.
Publicado: (2021)

Refractory Rheumatic Disorder: Atypical Postpregnancy Osteoporosis
por: Mourgues, Cindy, et al.
Publicado: (2015)

Effects of anti-TNF therapy on ophtalmological complications in children with rheumatic diseases
por: Frkovic, Marijan, et al.
Publicado: (2014)

COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
por: Ouédraogo, Dieu-Donné, et al.
Publicado: (2020)

Relationship between beliefs about medicines, adherence to treatment, and disease activity in patients with rheumatoid arthritis under subcutaneous anti-TNFα therapy
por: Horne, Rob, et al.
Publicado: (2018)

Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study
por: Alvarez-Madrazo, Samantha, et al.
Publicado: (2019)

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
por: Schreiber, Stefan, et al.
Publicado: (2022)

Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease
por: Kim, Ji-Won, et al.
Publicado: (2022)

Therapeutics for rheumatic fever and rheumatic heart disease
por: Ralph, Anna P, et al.
Publicado: (2022)

Anti-Rheumatic Effect of Antisense Oligonucleotide Cytos-11 Targeting TNF-α Expression
por: Makalish, Tatyana P., et al.
Publicado: (2021)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases
por: Kiltz, Uta, et al.
Publicado: (2022)

A COMPARATIVE STUDY OF SUBCUTANEOUS NODULES IN RHEUMATIC FEVER AND RHEUMATOID ARTHRITIS
por: Dawson, M. H.
Publicado: (1933)

Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
por: Schreiber, Stefan, et al.
Publicado: (2022)

Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis
por: Min, Hong Ki, et al.
Publicado: (2022)

Health Education about Rheumatic Heart Disease: A Community-Based Cluster Randomized Trial: Rheumatic Heart Disease Educational Strategies
por: Oliveira, Kaciane K. B., et al.
Publicado: (2020)

Adherence to Secondary Prophylaxis Among Patients with Acute  Rheumatic Fever and Rheumatic Heart Disease
por: Woods, John A., et al.
Publicado: (2019)

Treatment of Inflammatory Rheumatism
por: Gibbs, O. C.
Publicado: (1854)

Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease
por: Mullen, Lisa M, et al.
Publicado: (2015)

Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
por: Carballo, Nuria, et al.
Publicado: (2021)

Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study
por: Hassan, Shadi, et al.
Publicado: (2016)

Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases
por: Sauzullo, Ilaria, et al.
Publicado: (2018)

Efficacy of Oral Vitamin Supplementation in Inflammatory Rheumatic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Nguyen, Yann, et al.
Publicado: (2020)

Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever
por: Kevat, Priya M, et al.
Publicado: (2020)

Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
por: Kevat, Priya M., et al.
Publicado: (2017)

Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review
por: Lavielle, Matthieu, et al.
Publicado: (2018)

Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
por: Carballo, Nuria, et al.
Publicado: (2022)

Education: The prevention of acute rheumatic fever and rheumatic heart disease in Malawi
por: Sanyahumbi, Amy, et al.
Publicado: (2019)

Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
por: Happonen, Kaisa E, et al.
Publicado: (2012)

Identification of latent tuberculosis infection in rheumatic patients under consideration for treatment with anti-TNF-α agents
por: Paluch-Oleś, Jolanta, et al.
Publicado: (2013)

Patients' independence of a nurse for the administration of subcutaneous anti-TNF therapy: A phenomenographic study
por: Larsson, Ingrid, et al.
Publicado: (2010)

Immunomics in inflammatory rheumatic diseases
por: Konthur, Z, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_o9ocrdmgq68s18riib48rr8h18